Immunology News and Research

Latest Immunology News and Research

Curing type 1 diabetes: an interview with Dr. Habib Zaghouani, MU School of Medicine

Type 1 diabetes is an attack by the immune system of the islet of Langerhans within the pancreas. Basically, the islet of Langerhans harbor beta cells, which produce insulin and when the islets are attacked, the beta cells destruct and there is no more insulin. When the insulin level goes low, blood glucose levels go high and that creates a problem.

28 Jun 2013

Janssen, Johnson & Johnson Innovation establish IBD research alliance with Mount Sinai

Janssen Biotech, Inc. and Johnson & Johnson Innovation announced today the establishment of a research alliance with The Icahn School of Medicine at Mount Sinai to advance the scientific understanding of inflammatory bowel disease and the discovery of next generation therapeutic solutions.

27 Jun 2013

Researchers use mobile application to improve asthma outcomes among minority adolescents

Researchers at Rush University Medical Center in Chicago, IL and The University of Illinois at Chicago are using the Internet and motivational multimedia coupled with positive reinforcement via a smartphone application to try to improve asthma outcomes among low-income, minority adolescents with asthma.

27 Jun 2013

Second Edition of Human Evolutionary Genetics now available

Garland Science is proud to announce the publication of the long-awaited Second Edition of Human Evolutionary Genetics by Jobling, Hollux, Hurles, Kivisild, and Tyler-Smith.

27 Jun 2013

Prader-Willi syndrome results in dysregulation of circadian and metabolic genes

Researchers with the UC Davis MIND Institute and Agilent Laboratories have found that Prader-Willi syndrome - a genetic disorder best known for causing an insatiable appetite that can lead to morbid obesity - is associated with the loss of non-coding RNAs, resulting in the dysregulation of circadian and metabolic genes, accelerated energy expenditure and metabolic differences during sleep.

26 Jun 2013

Researchers provide new revelations about intricate pathways involved in turning on T cells

A major study from researchers at the La Jolla Institute for Allergy and Immunology provides new revelations about the intricate pathways involved in turning on T cells, the body's most important disease-fighting cells, and was published today in the prestigious scientific journal Nature.

24 Jun 2013

Bacterial DNA more likely to integrate in the genome of tumors than in normal healthy cells

Bacterial DNA may integrate into the human genome more readily in tumors than in normal human tissue, according to a new study from the University of Maryland School of Medicine's Institute for Genome Sciences. Researchers analyzed genomic sequencing data available from the Human Genome Project, the 1,000 Genomes Project and The Cancer Genome Atlas (TCGA). They considered the phenomenon of lateral gene transfer (LGT), the transmission of genetic material between organisms in the absence of sex.

21 Jun 2013

New treatment option for patients with aortic stenosis

Robert Stoler, MD, FACC, FSCAI, director of the Cardiac Catheterization Lab at Baylor Heart and Vascular Hospital and co-medical director, Division of Cardiology, is leading Baylor's participation in an exciting clinical trial to research a new treatment option for AS patients.

From Medtronic 21 Jun 2013

Chemical hormone released due to stress can trigger mechanism for late onset of Alzheimer's disease

A chemical hormone released in the body as a reaction to stress could be a key trigger of the mechanism for the late onset of Alzheimer's disease, according to a study by researchers at Temple University.

20 Jun 2013

Scientists discover new mechanism to protect body from harmful bacteria

Scientists at the University of Calgary's Faculty of Medicine have discovered a mechanism that is used to protect the body from harmful bacteria. Platelets, a component of blood typically associated with clotting, were discovered to actively search for specific bacteria, and upon detection, seal it off from the rest of the body. The findings, which were published in Nature Immunology this week, provide the science community with a greater understanding of immunity.

19 Jun 2013

New blood test finds cancer-related microRNA in blood before tumor development

A new blood test developed in the Gastrointestinal Cancer Research Lab at Baylor Research Institute is showing very promising results for finding cancer-related microRNA in the blood before a tumor develops in the colon.

19 Jun 2013

Montana scientist receives ICAAC Young Investigator Award for research on memory responses to infection

Joshua Obar, Ph.D., Department of Immunology and Infectious Diseases, Montana State University-Bozeman, has been honored with a 2013 ICAAC Young Investigator Award for his research on factors affecting the regulation of immunological memory responses to infection.

19 Jun 2013

Scientists discover new anti-tuberculosis compound that kills drug-resistant TB bacteria

An international team led by scientists at The Scripps Research Institute (TSRI), the Howard Hughes Medical Institute and Albert Einstein College of Medicine of Yeshiva University has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis (TB) bacterium in two different ways.

18 Jun 2013

Certain gastrointestinal types of GVHD are associated with worsened quality of life and death

Joseph Pidala, M.D., M.S., assistant member of the Blood and Bone Marrow Transplant and Immunology programs at Moffitt Cancer Center, and colleagues from the Chronic Graft-Versus-Host Disease Consortium have determined that certain gastrointestinal and liver-related types of chronic graft-versus-host disease (GVHD) are associated with worsened quality of life and death.

18 Jun 2013

TWi Biotechnology completes patient enrollment in phase II trial of AC-201 for Gout Flare Prophylaxis

TWi Biotechnology, Inc. announced that it has completed the patient enrollment in a phase II trial of AC-201 for Gout Flare Prophylaxis during urate-lowering therapy. This randomized, double-blind, placebo-controlled Phase II study is conducted in 8 major medical centers in Taiwan.

18 Jun 2013

TSRI scientists identify highly promising new anti-tuberculosis compound

An international team led by scientists at The Scripps Research Institute, the Howard Hughes Medical Institute and Albert Einstein College of Medicine of Yeshiva University has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis bacterium in two different ways.

18 Jun 2013

Researchers are one step closer to treating type 1 diabetes

Researchers at Washington University School of Medicine in St. Louis have identified a way to trigger reproduction in the laboratory of clusters of human cells that make insulin, potentially removing a significant obstacle to transplanting the cells as a treatment for patients with type 1 diabetes.

14 Jun 2013

Pew funds early-career scientists researching the basis of perplexing health problems

Twenty-two of the nation's most enterprising researchers were named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts today. The scholarships provide flexible funding to early-career scientists researching the basis of perplexing health problems such as diabetes, autism, Parkinson's disease, and cancer.

14 Jun 2013

EULAR announces recipients of Meritorious Service Award

EULAR today announced the recipients of the 13th annual Meritorious Service Award at the opening of the European League Against Rheumatism Annual Congress.

14 Jun 2013

Pew funds 10 Latin American scientists to conduct research on world's most troubling health problems

Ten scientists were named Pew Latin American Fellows in the Biomedical Sciences by The Pew Charitable Trusts today. The fellowship provides support to advance grantees' research, enables them to study with prominent U.S. scientists, and invests seed capital to help them establish laboratories in their home countries.

14 Jun 2013

Immunology News and Research

Latest Immunology News and Research

Curing type 1 diabetes: an interview with Dr. Habib Zaghouani, MU School of Medicine

Janssen, Johnson & Johnson Innovation establish IBD research alliance with Mount Sinai

Researchers use mobile application to improve asthma outcomes among minority adolescents

Second Edition of Human Evolutionary Genetics now available

Prader-Willi syndrome results in dysregulation of circadian and metabolic genes

Researchers provide new revelations about intricate pathways involved in turning on T cells

Bacterial DNA more likely to integrate in the genome of tumors than in normal healthy cells

New treatment option for patients with aortic stenosis

Chemical hormone released due to stress can trigger mechanism for late onset of Alzheimer's disease

Scientists discover new mechanism to protect body from harmful bacteria

New blood test finds cancer-related microRNA in blood before tumor development

Montana scientist receives ICAAC Young Investigator Award for research on memory responses to infection

Scientists discover new anti-tuberculosis compound that kills drug-resistant TB bacteria

Certain gastrointestinal types of GVHD are associated with worsened quality of life and death

TWi Biotechnology completes patient enrollment in phase II trial of AC-201 for Gout Flare Prophylaxis

TSRI scientists identify highly promising new anti-tuberculosis compound

Researchers are one step closer to treating type 1 diabetes

Pew funds early-career scientists researching the basis of perplexing health problems

EULAR announces recipients of Meritorious Service Award

Pew funds 10 Latin American scientists to conduct research on world's most troubling health problems

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging